Lantern Pharma Inc. (LTRN) Operating cash flow 2019–2025
Lantern Pharma Inc. (LTRN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$15.7MFY2025 · since FY2019: -$2.1M → -$15.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.7M | +12.0% |
| FY2024 | -$17.8M | -24.2% |
| FY2023 | -$14.3M | -12.4% |
| FY2022 | -$12.8M | -20.5% |
| FY2021 | -$10.6M | -87.4% |
| FY2020 | -$5.7M | -165.6% |
| FY2019 | -$2.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice